Safety and Efficacy of Antiangiogenesis Agents in Patients With Squamous Cell Carcinoma of the Lung: Time to Revise Outdated Constraints Fig 1. (A) Cross-trial comparison of response rate (ORR %) and ...

Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing. Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy ...

A small cell lung cancer (SCLC) misdiagnosis is possible. This can occur because of challenges during the diagnostic tests and because SCLC may share symptoms and causes similar to other conditions.

On the heels of two FDA approvals in lung cancer treatments, what innovations are next? As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes Small cell lung cancer (SCLC) is an uncommon, aggressive ...

Chemotherapy is a treatment that may be used for non-small cell lung cancer. It’s often used in combination with other treatment types. Chemotherapy is associated with a variety of risks and benefits.

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system. This ...